IL6 and COVID-19: In-patients with moderate-to-severe COVID-19 who received single-strain probiotic Bifidobacterium boosters were found to have significantly shorter hospital stays, IL-6 level reductions, radiological lung improvements, and lower mortality rates relative to the non-probiotic group (Bozkurt and Bilen, 2021).